My own view is that the science behind using OvADx to detect cancer is not very good, hence the difficulty of getting financing to get it FDA approved.
I don’t think it would matter if it is owned by AVDX or ARYC.
Recall several tests of this type of cancer detection has already been funded.
Like everything the Schena clan does it is just hype.
News 
Market Data 
Discover 
